Skip to content

A Phase 1 Trial to Evaluate the Safety, PK, and PD of AX-0811 in Healthy Participants

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-526764-21-00
Enrollment
44
Registered
2026-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholestatic disease

Interventions

None listed

Sponsors

ProQR Therapeutics VIII B.V.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 26, 2026